API | zofenopril

zofenopril Report issue

Small molecule Experimental

AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW

Zofenopril (INN) is a medication that protects the heart and helps reduce high blood pressure. It is an angiotensin-converting enzyme (ACE) inhibitor. ^Wikipedia

Chemistry

SMILES: C[C@H](CSC(=O)c1ccccc1)C(=O)N2C[C@H](C[C@H]2C(=O)O)Sc3ccccc3
InChIKey: IAIDUHCBNLFXEF-MNEFBYGVSA-N
Mol. Mass: 429.56
ALogP: 4.04 Partition coefficient
ChEMBL Molecules:

zofenopril

zofenoprilat

zofenopril calcium

More Chemistry

Pharmacology

Mechanism of Action:
- Angiotensin-converting enzyme 2 (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

Organizations (5)

Research & Development (5)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (3)

Approved Indications (1)

Hypertension

Experimental Indications - Clinical Trial Phases 1-4 (3)

Diabetes Mellitus, Type 2 (Phase 4)

Heart Diseases (Phase 4)

Hypertension (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 4
# of Trial Organizations: 5

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue